BioMed X Launches New T Cell Immunology Discovery Platform
A new technology developed by BioMed X in collaboration with Janssen functionally identifies and validates T cell target antigens, making it a powerful tool for...
BioMed X and AbbVie Extend Research Collaboration in the US
BioMed X establishes its first US-based institute in New Haven with a new immunology research project in collaboration with AbbVie. BioMed X, an independent German biomedical...